NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 60 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $10,088,000 | -2.1% | 7,609,000 | 0.0% | 0.43% | -34.9% |
Q1 2021 | $10,305,000 | +148.0% | 7,609,000 | +153.6% | 0.66% | +20.3% |
Q3 2020 | $4,155,000 | -86.5% | 3,000,000 | -87.5% | 0.55% | -89.2% |
Q1 2020 | $30,877,000 | +168.0% | 24,000,000 | +220.0% | 5.11% | +138.4% |
Q4 2019 | $11,522,000 | – | 7,500,000 | – | 2.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |